A Low Body Fat Mass Ratio Predicts Poor Prognosis in Patients with Advanced Non-Small Cell Lung Cancer

References

• Morgensztern D, Ng SH, Gao F, Govindan R. Trends in stage distribution for patients with non-small cell lung cancer: a National Cancer Database survey. J Thorac Oncol. 2010;5(1):29–e33. doi:10.1097/JTO.0b013e3181c5920c
   PubMed Web of Science ®Google Scholar
• Remon J, Ahn M-J, Girard N, Johnson M, Kim D-W, Lopes G, Pillai RN, Solomon B, Villacampa G, Zhou Q, et al. Advanced-stage non-small cell lung cancer: advances in thoracic oncology 2018. J Thorac Oncol. 2019;14(7):1134–55. doi:10.1016/j.jtho.2019.03.022
   PubMed Web of Science ®Google Scholar
• Cuyún Carter G, Barrett AM, Kaye JA, Liepa AM, Winfree KB, John WJ. A comprehensive review of nongenetic prognostic and predictive factors influencing the heterogeneity of outcomes in advanced non-small-cell lung cancer. Cancer Manag Res. 2014;6:437–e49. doi:10.2147/CMAR.S63603
   PubMed Web of Science ®Google Scholar
• Paesmans M, Berghmans T, Dusart M, Garcia C, Hossein-Foucher C, et al. Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project. J Thorac Oncol. 2010;5(5):612.
   PubMedGoogle Scholar
• Pawelczyk K, Piotrowska A, Ciesielska U, Jablonska K, Gletzel-Plucinska N, Grzegrzolka J, Podhorska-Okolow M, Dziegiel P, Nowinska K. Role of PD-L1 expression in non-small cell lung cancer and their prognostic significance according to clinicopathological factors and diagnostic markers. IJMS. 2019;20(4):824. doi:10.3390/ijms20040824
   Google Scholar
• Sarhill N, Mahmoud FA, Christie R, Tahir A. Assessment of nutritional status and fluid deficits in advanced cancer. Am J Hosp Palliat Care. 2003;20(6):465–73. doi:10.1177/104990910302000610
   PubMedGoogle Scholar
• Simmons CP, Koinis F, Fallon MT, Fearon KC, Bowden J, Solheim TS, Gronberg BH, McMillan DC, Gioulbasanis I, Laird BJ. Prognosis in advanced lung cancer–A prospective study examining key clinicopathological factors. Lung Cancer. 2015;88(3):304–9. doi:10.1016/j.lungcan.2015.03.020
   PubMed Web of Science ®Google Scholar
• Pencharz PB, Azcue M. Use of bioelectrical impedance analysis measurements in the clinical management of malnutrition. Am J Clin Nutr. 1996;64(3 Suppl):485S–8S. doi:10.1093/ajcn/64.3.485S
   PubMed Web of Science ®Google Scholar
• Ward LC, Müller MJ. Bioelectrical impedance analysis. Eur J Clin Nutr. 2013;67(Suppl 1):S1. doi: 10.1038/ejcn.2012.148,2013.
   PubMedGoogle Scholar
• Ebadi M, Mazurak VC. Potential biomarkers of fat loss as a feature of cancer cachexia. Mediators Inflamm. 2015;2015:1–8. doi:10.1155/2015/820934
   Google Scholar
• Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, Heitmann BL, Kent-Smith L, Melchior J-C, Pirlich M, Composition of the ESPEN Working Group, et al. Bioelectrical impedance analysis-part I: review of principles and methods . Clin Nutr. 2004;23(5):1226–43. doi:10.1016/j.clnu.2004.06.004
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982;5(6):649–55.
   PubMed Web of Science ®Google Scholar
• Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr. 2000;72(3):694–701. doi:10.1093/ajcn/72.3.694
   PubMed Web of Science ®Google Scholar
• Flegal KM, Shepherd JA, Looker AC, Graubard BI, Borrud LG, Ogden CL, Harris TB, Everhart JE, Schenker N. Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. Am J Clin Nutr. 2009;89(2):500–8. doi:10.3945/ajcn.2008.26847
   PubMed Web of Science ®Google Scholar
• Ross PJ, Ashley S, Norton A, Priest K, Waters JS, Eisen T, Smith IE, O’Brien MER. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers? Br J Cancer. 2004;90(10):1905–11. doi:10.1038/sj.bjc.6601781
   PubMed Web of Science ®Google Scholar
• Wei M, Xie C. Weight loss predicts poor prognosis in patients treated with concurrent chemoradiotherapy for stage III non-small cell lung cancer. Biomed Res. 2017;28(14):6308–13.
   Google Scholar
• Murphy RA, Wilke MS, Perrine M, Pawlowicz M, Mourtzakis M, Lieffers JR, Maneshgar M, Bruera E, Clandinin MT, Baracos VE, et al. Loss of adipose tissue and plasma phospholipids: relationship to survival in advanced cancer patients. Clin Nutr. 2010;29(4):482–7. doi:10.1016/j.clnu.2009.11.006
   PubMed Web of Science ®Google Scholar
• Fouladiun M, Körner U, Bosaeus I, Daneryd P, Hyltander A, Lundholm KG. Body composition and time course changes in regional distribution of fat and lean tissue in unselected cancer patients on palliative care—correlations with food intake, metabolism, exercise capacity, and hormones. Cancer. 2005;103(10):2189–98. doi:10.1002/cncr.21013[Mismatch]C
   PubMedGoogle Scholar
• Pereira MME, Queiroz MDSC, de Albuquerque NMC, Rodrigues J, Wiegert E, et al. The prognostic role of phase angle in advanced cancer patients: a systematic review. Nutr Clin Pract. 2018;33(6):813–24.
   PubMed Web of Science ®Google Scholar
• Gupta D, Lis CG, Dahlk SL, Vashi PG, Grutsch JF, Lammersfeld CA. Bioelectrical impedance phase angle as a prognostic indicator in advanced pancreatic cancer. Br J Nutr. 2004;92(6):957–62. doi:10.1079/BJN20041292
   PubMed Web of Science ®Google Scholar
• Gupta D, Lammersfeld CA, Burrows JL, Dahlk SL, Vashi PG, Grutsch JF, Hoffman S, Lis CG. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in advanced colorectal cancer. Am J Clin Nutr. 2004;80(6):1634–8. doi:10.1093/ajcn/80.6.1634
   PubMed Web of Science ®Google Scholar
• Toso S, Piccoli A, Gusella M, Menon D, Bononi A, Crepaldi G, Ferrazzi E. Altered tissue electric properties in lung cancer patients as detected by bioelectric impedance vector analysis. Nutrition. 2000;16(2):120–4. doi:10.1016/S0899-9007(99)00230-0
   PubMed Web of Science ®Google Scholar
• Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, Lis CG. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer. 2008;8(1):249. doi:10.1186/1471-2407-8-249
   PubMed Web of Science ®Google Scholar
• Ott M, Fischer H, Polat H, Helm EB, Frenz M, et al. Bioelectrical impedance analysis as a predictor of survival in patients with human immunodeficiency virus infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;9:20–5.
   PubMedGoogle Scholar
• Gupta D, Lammersfeld CA, Vashi PG, King J, Dahlk SL, Grutsch JF, Lis CG. Bioelectrical impedance phase angle in clinical practice: implications for prognosis in stage IIIB and IV non-small cell lung cancer. BMC Cancer. 2009;9(1):37. doi:10.1186/1471-2407-9-37
   PubMedGoogle Scholar
• Wu M, Wang Y, An T, Zhao J, Yang L, et al. Analysis of prognostic factors in 541 female patients with advanced non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 2011;14(3):245–50. doi:10.3779/j.issn.1009-3419.2011.03.21
   PubMedGoogle Scholar
• Sánchez-Lara K, Turcott JG, Juárez E, Guevara P, Núñez-Valencia C, Oñate-Ocaña LF, Flores D, Arrieta O. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study. Nutr Cancer. 2012;64(4):526–34. doi:10.1080/01635581.2012.668744
   PubMed Web of Science ®Google Scholar
• Ebadi M, Martin L, Ghosh S, Field CJ, Lehner R, Baracos VE, Mazurak VC. Subcutaneous adiposity is an independent predictor of mortality in cancer patients. Br J Cancer. 2017;117(1):148–55. 27 doi:10.1038/bjc.2017.149
   PubMed Web of Science ®Google Scholar
• Daghfous H, El Ayeb W, Alouane L, Tritar F. Evaluation de l’état nutritionnel par impédencemétrie et Test MNA au cours de cancer primitive du poumon [Evaluation of nutritional Status in lung cancer using bio electrical impedance analysis and mini nutritional assessment. ]. Tunis Med. 2014;92(12):737–42.
   PubMedGoogle Scholar
• Nilsson J, Berglund A, Bergström S, Bergqvist M, Lambe M. The role of comorbidity in the management and prognosis in nonsmall cell lung cancer: a population-based study. Acta Oncol. 2017;56(7):949–56. doi:10.1080/0284186X.2017.1324213
   PubMed Web of Science ®Google Scholar
• Abdul Aziz NS, Shahar S, Ambak R, Mohamad Nor NS, Jamil AT. Influence of co-morbidity on body composition changes after weight loss intervention among overweight housewives: a follow-up study of the MyBFF@home. BMC Womens Health. 2018;2018(Suppl 1):115.
   Google Scholar
• Al-Sofiani ME, Ganji SS, Kalyani RR. Body composition changes in diabetes and aging. J Diabetes Complications. 2019;33(6):451–9. doi:10.1016/j.jdiacomp.2019.03.007
   PubMed Web of Science ®Google Scholar